Limiting medical drugs
Description
Limiting medical drugs involves implementing regulations and controls to restrict the availability, prescription, and distribution of pharmaceuticals. This strategy aims to prevent misuse, overprescription, and the development of drug resistance, while ensuring essential medicines remain accessible for legitimate medical needs. Practical actions include establishing prescription guidelines, monitoring drug sales, enforcing legal restrictions, and promoting public awareness to reduce health risks associated with inappropriate drug consumption and to safeguard public health systems.
Context
Every day 76 million valium tablets are taken in the USA.
Claim
Certain drugs should be "forbidden", that is more restricted than prescription drugs. This would allow regulators to feel more secure in releasing new drugs to some members of the public whilst making them unavailable to the majority. Categories of "forbidden" drugs might be:
- Those prescritible only by specialists;
- Prescriptible only to the desperate, eg those with life-threatening or incurable illnesses, or to those who have not been helped by any other remedy;
- Drugs administered only in "dedicated" institutions or treatment of some particular condition, eg centres which treat rare diseases, or hospices for the dying, or alcohol and drug treatment centres. One or more restriction could be imposed simultaneously. One benefit of these minutely graduated categories is that drugs could be released to the public by degrees. Initially access would be quite restricted; at first new drugs might be prescsriptable only by specialist, and/or only to the desperate, and/or only in special centres, ie to patients and under circumstances in which taking greater risks than the average patient is justified. By degrees restriction would gradually diminish as safety and efficacy was proved, with the early users performing a guinea-pig function for the rest of the population.
Broader
Narrower
Constrains
Constrained by
Facilitates
Facilitated by
Problem
Value
SDG
Metadata
Database
Global strategies
Type
(D) Detailed strategies
Subject
Content quality
Unpresentable
Language
English
1A4N
Q0619
DOCID
12706190
D7NID
207597
Editing link
Official link
Last update
Mar 21, 2022